Which test should be used to screen for HIV following a needlestick injury in a nurse?

HIV Testing After Needlestick Injury

For immediate HIV screening following a needlestick injury, use an FDA-approved rapid HIV antibody test or laboratory-based HIV antigen/antibody combination test to expedite results and guide postexposure prophylaxis decisions. 1

Immediate Testing Strategy

Source Patient Testing

• Test the source patient immediately using an FDA-approved rapid HIV antibody test kit, particularly if standard enzyme immunoassay (EIA) cannot be completed within 24-48 hours 2
• Repeatedly reactive results by EIA or rapid HIV antibody tests are highly suggestive of infection and sufficient for initial postexposure management decisions 2
• Western blot or immunofluorescent antibody confirmation is not necessary for making initial PEP decisions, though it should be completed to finalize the testing process 2
• Obtain consent from the source patient consistent with local statutes to determine serologic status for HIV, hepatitis B, and hepatitis C 1

Exposed Healthcare Worker Baseline Testing

• Perform baseline HIV antibody testing on the exposed nurse to establish serostatus at the time of exposure 2
• If the source person is HIV-negative with no clinical evidence of AIDS or recent high-risk behaviors, baseline testing or further follow-up of the healthcare worker is typically not necessary 2
• Obtain consent and test for HIV antibody as part of determining the immunity status of the exposed employee 1

Follow-Up Testing Schedule

For Healthcare Workers Who Receive PEP

• At 6 weeks post-exposure: Perform HIV antibody testing 3
• At 3 months post-exposure: Repeat HIV antibody testing 3
• At 6 months post-exposure: Final HIV antibody testing to definitively rule out infection 3
• Monitor the exposed healthcare worker taking PEP within 72 hours after exposure and continue monitoring for drug toxicity for at least 2 weeks 3

For Healthcare Workers Who Do NOT Receive PEP

• If PEP is not indicated (e.g., source is HIV-negative), follow-up testing may be limited or unnecessary depending on the source's risk profile 2
• If the source recently engaged in high-risk behaviors despite negative testing, consider baseline and follow-up testing at 3 and/or 6 months 2

Critical Timing Considerations

Antiretroviral prophylaxis must be initiated as soon as possible but within 24 hours of exposure to maximize effectiveness 1. This urgency makes rapid HIV testing of the source patient essential, as treatment decisions cannot wait for standard laboratory turnaround times.

Common Pitfalls to Avoid

• Do not test discarded needles or syringes for virus contamination—the reliability and interpretation of such findings are unknown 3
• Do not delay PEP initiation while waiting for confirmatory Western blot results; repeatedly reactive rapid tests or EIA results are sufficient to guide initial management 2
• Do not assume a negative source test is definitive if the source has recent high-risk exposures within the past 3-6 months, as they may be in the window period 2
• Ensure all employees know how to access the exposure management policy and understand the importance of immediate reporting 1

Additional Baseline Assessments

Beyond HIV testing, the initial evaluation should include:

• Testing for hepatitis B surface antigen (HBsAg) status of the source 1
• Testing for hepatitis C antibodies in both source and exposed worker 1
• Determining the exposed worker's hepatitis B vaccination status and anti-HBsAg response 1
• Pregnancy testing for women of childbearing age whose pregnancy status is unknown 2